Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 9.59M $643.71M March 31, 2014
Wellington Management Company 8.04M $540.11M March 31, 2014
T. Rowe Price Associates 3.59M $241.35M March 31, 2014
Vanguard 2.68M $180.04M March 31, 2014
Franklin Resources 2.60M $174.52M March 31, 2014
BlackRock Fund Advisors 2.31M $155.09M March 31, 2014
Gilder, Gagnon, Howe & Co 1.92M $128.61M March 31, 2014
HealthCor Management 1.80M $16.87M June 30, 2011
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.67M $112.16M March 31, 2014
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 1.52M $102.09M March 31, 2014
HealthCor Management 1.45M $35.34M March 31, 2013
STATE STREET CORPORATION 1.43M $95.80M March 31, 2014
Bridger Management 1.37M $33.31M March 31, 2013
Jennison Associates 1.22M $81.80M March 31, 2014
CITADEL ADVISORS 1.19M $36.84M June 30, 2013
Wells Fargo & Company 1.17M $78.46M March 31, 2014
Abingworth 1.11M $20.29M Dec. 31, 2012
BlackRock Advisors 1.10M $70.19M Sept. 30, 2013
BAILLIE GIFFORD & CO 1.07M $72.03M March 31, 2014
Capital World Investors^ 1.05M $67.85M Dec. 31, 2013
LORD, ABBETT & CO 1.03M $31.83M June 30, 2013
Columbus Circle Investors 1.00M $67.43M March 31, 2014
Falcon Edge Capital 1000000 $64.30M Dec. 31, 2013
Camber Capital Management 1000000 $31.01M June 30, 2013
Columbia Wanger Asset Management 902764 $60.61M March 31, 2014
NORTHERN TRUST 767144 $51.50M March 31, 2014
MORGAN STANLEY 739186 $49.67M March 31, 2014
Deerfield Management Company 694000 $21.51M June 30, 2013
Renaissance Technologies 647200 $7.16M March 31, 2012
S.A.C. Capital Advisors 620449 $19.24M June 30, 2013
TimesSquare Capital Management 602900 $38.77M Dec. 31, 2013